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Abstract 
Silver and silver-based products are known to cause cytotoxic effects to both microbes and 
eukaryotic cells. Because of this property, silver nanoparticles (AgNPs) are being studied for their 
potential in targeted tumor treatments. Previous studies with microbes suggest that AgNPs with 
cationic capping agents possess enhanced cytotoxicity by virtue of Coulombic attraction between 
the nanoparticle and the negatively-charged cell wall. Since animal cells possess similar 
negatively-charged plasma membranes, this research hypothesized that human cells would be 
more susceptible to positively-charged AgNPs than to negatively-charged AgNPs. To investigate 
this theory, cancerous cervical cells (HeLa) and healthy fibroblast cells (3T3) were subjected to 
treatments of 40 nm diameter AgNPs with branched polyethylenimine (AgBPEI, ζ = + 69 mV) 
and citrate (AgCit, ζ = - 49 mV) capping agents. AgNO3 was also tested to compare AgNP toxicity 
to that of ionic silver (Ag+). An alamarBlue® viability assay was used to quantify the cytotoxicity 
of the treatments relative to an untreated control group.  AgBPEI displayed a lower LD50 than did 
Ag+ and AgCit to both cell lines. This suggests AgNP toxicity is not solely from Ag+ dissolution, 
and also ostensibly supports the initial hypothesis. However, significant AgCit aggregation was 
observed in culture media, which obfuscates surface charge-based toxicity effects because larger 
diameter AgNPs are less cytotoxic. Thus size-dependent toxicity must also be considered, although 
this is not expected to negate surface charge effects.  Moreover, since AgBPEI is more stable than 
AgCit under in vitro conditions, these results suggest that researchers investigating AgNPs for 
targeted tumor treatments should utilize AgBPEI over AgCit on the premise of enhanced 
biovailability. 
 
Keywords: 
silver nanoparticles, surface charge, cytotoxicity, cancer cells, tumor, targeted therapy, capping 
agent, Coulombic, branched polyethylenimine, citrate, viability assay, aggregation, media 
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I. Introduction 
A.  Background 
Nanosilver, or silver nanoparticles (AgNPs), are silver particles that do not exceed 100 nanometers 
in any dimension. Within a medical context, AgNPs are known for their anti-bacterial, anti-fungal, 
anti-viral, and anti-inflammatory [1] properties. For example, AgNPs are used as germicidal agents 
in everyday items such as socks, cosmetics, washing machines, food packaging, water 
disinfectants, sponges, and toothbrushes [2]. AgNPs are also increasingly used in the biomedical 
field for diagnostics and imaging, wound dressings, and medical device coatings [3], and are 
recently being investigated for their potential4as therapeutic5agents6for tumor7treatments  [4-8]. 
Because targeted tumor treatments hope to isolate and selectively destroy cancerous tissue, they 
offer a potentially enormous advantage over the widespread side effects caused by traditional 
chemotherapy methods. 
 
B.  Problem Statement 
The continually increasing list of applications of AgNPs necessitates a deeper understanding of 
the way in which nanosilver interacts with biological matter. However, the relative novelty of 
silver nanotechnology has limited definitive conclusions and consensus within the scientific 
community. For example, research into the consequences of long-term exposure to nanosilver by 
both humans and the environment is ongoing; the only thing agreed upon is that silver 
nanomaterials should be evaluated on a case-by-case basis [9] and that cytotoxic effects are 
contingent on their physicochemical properties [10]. Most researchers agree that while the release 
of Ag+ ions is the predominant mechanism of cytotoxicity, this alone does not account for the 
totality of the biological response to AgNPs, and that other nanoparticle-specific mechanisms exist 
[10,11]. These cytotoxic mechanisms may be aided or hindered by altering the size, shape, and 
surface properties of13AgNPs [12-14]. It is within this context, and encouraged by current interest in 
AgNPs for cancer treatments, that the effect of AgNP surface charge on cytotoxic efficacy is being 
studied in this work. 
 
C. Hypothesis  
While research indicates that surface charge plays a pivotal role in the cytotoxicity of AgNPs on 
prokaryotes [14], little is known about the eukaryotic response to AgNP surface charge. Since 
eukaryotic cells are surrounded by a negatively-charged phospholipid membrane, it is expected 
that AgNPs with cationic capping agents will display superior cytotoxicity over anionic capping 
agents by virtue of increased nanoparticle interaction. This trend was explicitly pointed out in a 
2013 study that measured cytotoxicity of different AgNPs towards planktonic crustacean samples 
[15], which share similar animal cell membrane physiology with humans. Further study—especially 
with human cells—is required before categorical inferences about surface charge dependent 
cytotoxicity in eukaryotes can be made. If this hypothesis holds true, then this discovery may be 
of value to those developing AgNPs for targeted tumor treatments. In other words, utilizing 
positively charged capping agents may enhance the efficacy of silver nanoparticles in killing 
cancerous cells. 
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D. Literature Review 
AgNPs engender cytotoxic effects in both microbes and eukaryotic cells through a variety of 
mechanisms. These include: activation of cell signaling pathways, which can inhibit proliferation 
[16]; damage to cellular constituents, such as destabilization of the cell membrane or mitochondria 
[11]; induction of reactive oxygen species (ROS) from mitochondrial dysfunction [17], which can 
initiate DNA fragmentation, chromosomal aberrations, and ultimately cell cycle arrest and/or 
apoptosis [12,18]; direct interruption of the electron transport chain, subsequent metabolic arrest, and 
hindered viability [11]; and lastly AgNP endocytosis and subsequent Ag+ ion release into the 
cytoplasm, which attacks thiol-containing proteins and binds with chlorine ligands [19]. These 
mechanisms are graphically summarized in Figure 1. It should be noted that the severity of these 
deleterious effects are contingent on a variety of factors, ranging from nanoparticle size, shape, 
and surface properties to environmental stability and bioavailability to the target cell, cell type, 
and duration of cell exposure [20].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Because cytotoxic AgNPs can be functionalized to specifically target tumor cells, they are being 
studied by cancer researchers [4-8]. AgNPs have been found to be preferentially cytotoxic to cancer 
cells over healthy cells because cancerous cells have impaired DNA repair pathways, making them 
more susceptible to ROS-mediated genotoxicity [18]. Moreover, the tumor environment is more 
acidic than healthy cells, which may encourage silver ion dissolution and engender further 
preferential toxicity [8].  
 
Figure 1. Proposed AgNP toxicity mechanisms on animal cells [16]. 
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Although an investigation into the exact mechanisms in which silver nanoparticles cause cancerous 
cell death is beyond the scope of this work, it is feasible to isolate and study a single parameter of 
AgNP tumor treatments. In 2011, El Badawy et al. found that AgNPs grafted with cationic polymer 
branched polyethylenimine (AgBPEI) were more cytotoxic to Bacillus species than those grafted 
with anionic citrate (AgCit) [14]. It was speculated that this was the result of Coulombic attraction 
between the positive surface charge of the AgBPEI and the negative surface charge of teichoic 
acids in the peptidoglycan cell wall of Bacillus microbes. This hypothesis was supported by a 2013 
study where AgBPEI was more toxic than AgCit to E.coli microbes with similar Gram negative 
cell wall compositions as Bacillus species. Atomic force microscopy was performed to illustrate 
the outcome of enhanced AgBPEI interaction with the microbes’ cell walls (Figure 2) [10]. Because 
of this enhanced interaction, cytotoxic effects—regardless of mechanism—were increased. This 
trend was independently confirmed by researchers studying the influence of AgNP surface charge 
in other microbial treatments [15,21], showing that surface charge is influential in the cytotoxicity of 
AgNPs on prokaryotes. 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
However, mammalian cell response to changes in AgNP surface charge is unknown. Mammalian 
cells possess a negatively charged phospholipid membrane [22,23], so it is not unreasonable to 
speculate that AgNPs with positively-charged capping agents will interact with and kill 
mammalian cells more so than those with negatively-charged capping agents. In support of this 
hypothesis, it was found that gold nanoparticles with cationic coatings displayed significantly more 
interaction with a model cell membrane than those with anionic coatings [24]. Should this 
hypothesis hold, it would be of particular interest in regards to cancer cells, which have a more 
negative surface charge than healthy cells [22,25]. A 2013 study into the ecotoxicity of AgNPs with 
varying capping agents revealed that the eukaryote Daphnia magna, a planktonic crustacean, was 
indeed more susceptible to AgBPEI (ζ = +28.8 mV, pH 7.1) treatments than AgCit treatments (ζ 
= -20.08 mV, pH 7.2) [15]. Considering both crustaceans and humans share the same general animal 
cell physiology, a similar cytotoxic response to AgNP surface charge should be observed. 
Figure 2. Atomic force microscope images showing AgCit (left) and AgBPEI (right) interacting with E. 
coli cells.  Significantly more AgBPEI is deposited on E. coli cell walls than AgCit. The scale bar denotes 1 
micron [10]. 
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E. Design of Experiment  
Cancerous HeLa cells and healthy 3T3 fibroblast cells were subjected to AgNP treatments of 
varying surface charge and concentration. The AgNPs were spherical, of identical diameter, and 
sterilized to limit confounding cytotoxic effects of shape, size, and biological contaminants. To 
achieve AgNPs with opposite surface charge, branched polyethylenimine (BPEI) and citrate (Cit) 
were chosen as AgNP capping agents—each of which was tested as a cytotoxicity control. Also 
tested was silver nitrate (AgNO3) to provide comparison to the cytotoxicity of ionic silver (Ag
+). 
Cytotoxicity testing was performed via the alamarBlue® viability assay. Lethal dose 50% (LD50) 
values were calculated to quantify cytotoxicity trends. Cell culture morphology was inspected with 
light microscopy before and after treatment to detect contamination and to ensure culture growth. 
Lastly, the nanoparticles were characterized for diameter and size distribution with dynamic light 
scattering (DLS) to verify nanoparticle stability in media. Transmission electron microscope 
(TEM) images and zeta potential data for the AgNPs were collected from the manufacturer to 
ensure product quality. 
 
Once the data was collected, the response of healthy and cancerous human cells to oppositely 
charged AgNPs could be compared and screened against BPEI, Cit, and Ag+ ions. If results show 
that AgBPEI is more cytotoxic than AgCit, and neither the negative controls nor the aggregation 
study indicate confounding affects, conclusions regarding the influence of surface charge on 
cytotoxicity can be made. It may then also be beneficial to utilize cationic capping agents over 
anionic capping agents for future AgNP cancer research and other inherent toxicity applications. 
 
F. Objective(s) 
This study endeavored to explicitly determine if positively-charged AgNPs are more cytotoxic 
than negatively-charged AgNPs when applied to both healthy and cancerous human cells. To do 
so, the cytotoxicity of positively-charged, cation-capped AgNPs (ζ > 0) was compared to that of 
negatively-charged, anion-capped AgNPs (ζ < 0). This was done in hopes of finding a more 
suitable AgNP for targeted tumor research.  
This experiment was setup in a way that allows for several other auxiliary objectives to be 
investigated. First, by also testing silver nitrate at the same concentrations as the AgNPs, the 
toxicity of AgNPs can be compared to that of Ag+. This allows insight into how much of AgNP 
toxicity is due to ion dissolution. Second, by performing DLS on the AgNPs at relevant treatment 
concentrations in media, aggregation effects may be elucidated. This is not only crucial for 
properly interpreting toxicity results, but also for determining which capping agent provides more 
AgNP stability in media. 
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II. Methods and Materials 
A. Cell Culture  
1. Cell Culturing  
Cancerous HeLa cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM) 
supplemented with 10% fetal bovine serum (FBS) and 1% penicillin streptomycin. (HeLa 
cells, a human cervical cancer cell line, are commonly utilized in biotechnology and 
pharmaceutical research as a generic cancer cell line.) Healthy 3T3 fibroblast cells were 
maintained in the same media. (Although 3T3 cells are derived from mice, they are a valid 
and recommended substitution for human fibroblasts in nanotoxicology studies because of 
their wide availability and their similarity to human fibroblasts.) Cultures were maintained 
in a 5% CO2 incubator at 37
oC. Cell lines were maintained in aerated, sterilized T25 
polystyrene flasks (25 cm2 bottom) and were split biweekly with fresh media to ensure 
nutrient availability, to limit population constraints, and to remove toxic metabolic 
products.  Sterile cell culturing protocols were followed to prevent bacterial or chemical 
contamination [26]. A sample flask is shown in Figure 3.  
 
  
 
 
 
 
 
 
 
 
 
 
 
2. Cell Splitting  
Adherent mammalian cultures were split during the logarithmic phase of population growth 
to prevent confluent (contact) inhibition of further growth. This was roughly every three 
days, as determined by medium turbidity and a pH drop caused by lactic acid buildup 
(measured using litmus paper). This procedure is required to ensure the long-term survival 
of the cell culture. It replenishes media nutrients, removes dead cells and accumulated 
metabolic products, and prevents the cell concentration within the flask from increasing to 
levels where nutrient and physical space requirements cannot be met. Protocols are listed 
in the cell culturing handbook [26]. 
 
 
 
Figure 3. The HeLa cell culture forms a monolayer in a T25 polystyrene flask. The lid is slightly 
ajar to allow for gas exchange between the culture and the environment.  
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3. Cell Counting  
Cell lines were split into two fresh flasks before experimental use. The parent flask was 
kept for the creation of the cell stock designated for AgNP treatments, whereas the two 
fresh flasks were placed back into the incubator to be maintained for future experiments. 
The parent flask was then subjected to a cell count using hemocytometry. A suitable 
amount of DMEM was added to this flask to create a cell stock solution with a 
concentration of 1x105 cells/mL.   
 
4. Cell Incubations  
100 µL of cell stock was allocated into each well of a sterile, optically transparent, 
polystyrene 96-well plate. Plates were left to incubate for 24 hours. This was done to 
eliminate false cytotoxicity positives caused by the biological shock of extensive pipetting. 
In this way, cell cultures could stabilize before treatment testing. Before treatments were 
applied, plates were inspected with a light microscope for contamination and culture 
growth.  
 
5. Cell Handling  
All cell handling was performed in a Class II biosafety cabinet (Figure 4). Appropriate 
safety protocols were followed (see Appendix A for details).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Tissue culture laboratory, Cal Poly Biology Department. The biosafety cabinet UV 
light is on to sterilize the work surface before use. The light microscope was used for cell culture 
inspections and hemocytometry. Separate biohazard disposal bins are present to contain either 
pipette tips and flasks or biological liquids. 
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B. Treatment Preparation 
1. In-House AgNP Synthesis 
For preliminary work, AgCit and AgBPEI were synthesized in-house. This provided 
inexpensive, readily available reagents for preliminary testing while experimental 
protocols were being established, as well as an opportunity to learn the fundamentals of 
AgNP chemistry. However, while cheaper and faster than ordering commercial AgNPs, 
these in-house AgNPs were not suitable for academic research. The AgNPs used in this 
study must be of the same diameter, have precise concentrations, and be contaminant-free.  
Significant time investment in experimentation and financial investment in outsourced 
characterization would have been required to develop a reliable, reproducible AgNP recipe 
suitable for academic use at Cal Poly. Therefore, rather than try to synthesize and 
characterize AgNPs in-house, it was a more prudent allocation of time and money to 
purchase small quantities of fully characterized, contaminant-free commercial AgNPs. 
 
2. Commercial AgNPs  
2 mL quantities of 1 µg/mL AgBPEI and AgCit solutions were purchased from 
NanoComposix (Figure 5). AgNPs arrived with manufacturer-provided characterization 
information (Table I). AgBPEI is electrosterically stabilized by a coating of BPEI that 
adsorbs onto the silver surface [27]. AgCit is surrounded by citrate anions that adsorb to the 
silver core through polar interactions and maintain colloidal stability through electrostatic 
repulsion [28]. Both types of AgNPs were purchased in 40 nm diameter size to deconvolute 
size-related cytotoxicity effects from surface charge. TEM images were provided by the 
manufacturer (Figure 6) to confirm AgNP size and morphology. The AgNPs were 
subjected to the manufacturer’s “BioPure” screening, meaning that residual reactants were 
removed, that endotoxin levels were confirmed to be below 2.5 EU/mL, and that solutions 
were sterilized.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. 1 µg/mL vials of AgCit (left) vs AgBPEI (right). Because the diameters are the same in 
both types of AgNP, the slight difference in color can be attributed to visible light interference by 
the capping agents.  
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3. AgNP Treatment Preparation  
AgBPEI and AgCit stock solutions of 100 µg/mL and 25 µg/mL were prepared in sterilized 
glass bottles by dilution with Millipore water. The Millipore water was micro-filtered in a 
sterile vacuum hood and then autoclaved to eliminate biological contamination.  
 
4. AgNO3  
Silver nitrate stocks of 100 µg/mL and 25 µg/mL were prepared in an identical fashion to 
the AgNPs. Because AgNO3 dissociates into Ag
+ and NO3
- in polar solutions, it is 
commonly used as a reagent for Ag+ toxicity. AgNO3 was chosen as a reference against 
which to compare the cytotoxicity of Ag+ versus AgNPs. Free NO3
- in AgNO3 treatments 
is known to have negligible effects on mammalian cells at the concentrations used in this 
study [29].  
 
5. Capping Agents  
Trisodium citrate and BPEI treatments were prepared as cytotoxicity controls to 
deconvolute the cytotoxic effects of the capping agents on cells.  
AgNP Size (TEM) Zeta Potentialc Capping Agent 
 
Stabilization 
AgCita 40 nm ζ = - 49 mV (pH 7.2) Citrate 
 
electrostatic 
AgBPEIb 40 nm ζ = + 69 mV (pH 8.1) Branched PEI 
 
electrosteric 
aAgCit prepared in solution with excess Na3C6H5O7 
bAgBPEI suspended in Milli-Q water  
c |ζ| ≥ 20 mV is considered a stable colloidal suspension 
Figure 6. TEM images of AgCit (left) and AgBPEI (right) provided by nanoComposix. 
Table I. Data for AgNPs Purchased from nanoComposix 
10  
 
C. alamarBlue® Viability Assay   
1. Theory 
Dye-based viability assays, such as alamarBlue® are an industrial and scientific standard 
for preliminary cytotoxicity screening [30]. The alamarBlue® assay was performed as a 
simple means of determining the extent to which mitochondrial activity was affected by 
the treatment. This test uses an indicator molecule—resazurin— that is reduced by 
metabolic activity to resorufin, a pink and highly fluorescent molecule. This chemical 
reduction occurs inside the host cell’s mitochondrial electron transport chain, where 
resazurin substitutes for O2 as a terminal electron receptor. The intensity of fluorescence 
produced is proportional to the number of living cells respiring, so fluorescence 
measurements can determine if the AgNP treatments hindered metabolic processes. 
Because metabolic activity is a primary indicator of cell viability, this assay can be used to 
measure the treated cells’ likelihood to survive and reproduce. alamarBlue® was chosen 
because it is non-toxic to both organisms and the experimenter, requires relatively few 
steps, and can be measured with fluorescence, which is more accurate than absorbance-
based assays. While the alamarBlue® assay can provide information regarding the 
proliferative capacity and overall “health” of the cells, it cannot provide direct information 
distinguishing the number of necrotic cells and those undergoing apoptosis. However, 
because dead or dying cells will display minimal reduction of the dye agent, and because 
rendering oncogenic cells non-viable is still considered a sign of an effective treatment, 
this viability assay is suitable for initial testing regarding cytotoxicity of various AgNP 
treatments.  
 
2. Day 1: Plate Preparation  
The two cell culture stocks were pipetted into separate 96-well plates to avoid cross-
contamination. A total volume of 115 µL was set for each well to mitigate volumetric 
fluorescent quenching effects during spectrophotometry. To accomplish this, 100 µL of 
cell culture stock was pipetted into treatment-designated wells, thus achieving the optimal 
cell count (1x104 cells/well) for the viability assay [31] and leaving 15 µL for treatment 
addition. After incubation at 37oC for 24 hours, plates were observed under a light 
microscope to inspect for cell growth and potential contamination.  
 
3. Day 2: Apply Treatments 
DMEM, and the corresponding treatments, were added to achieve the designated total well 
volume of 115 µL. Plate well allocation was determined by the fluorescent protocol 
employed for measurement. Thus, each cell plate had its own controls and blanks, thus 
minimizing experimental error between plates. The pertinent details of plate allocation are 
as follows: 
i. Silver Treatments. AgCit, AgBPEI, and AgNO3 treatments of 0.5, 1, 2.5, 5, 7.5, 
and 10 µg/mL concentrations were achieved through application of various stock 
volumes to the experimental wells. This range was chosen because initial studies 
with in-house nanoparticles, as well as prior work with commercial AgNPs, 
suggested an LD50 within this concentration range. This concentration range was 
also selected because it optimized plate well utilization for maximum data 
collection. 
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ii. Capping Agents. Citrate and BPEI were tested at 10 µg/mL to allow observation 
of any cytotoxicity of the polymers themselves. The highest concentration of AgNP 
treatments was 10 µg/mL, but this concentration accounts only for the mass of the 
AgNPs’ silver cores and not their capping agents. Because of the small volume of 
capping agent needed to cover the surface of the silver core, and because the density 
of silver is much higher than the polymeric capping agents, it can reasonably be 
assumed that the capping agent concentration in the AgNP treatments was 
considerably less than 10 µg/mL. Assuming an increase in potential toxicity with 
concentration, using 10 µg/mL of pure capping agent was more than sufficient to 
illustrate any potential toxicity of the capping agents. 
iii. Triplicate. Each AgNP treatment was prepared in triplicate for redundancy and to 
account for potential variance in cell density amongst wells delegated for the same 
treatment. Mean reduction values and standard deviation per treatment were 
collected from these three readings.  
iv. Positive Control. Positive control wells had 100 µL of cell culture and were subject 
to a 15 µL DMEM treatment to maintain consistency in well volumes. These wells 
represent optimal growth conditions for cells, as no cytotoxic treatments were 
applied. Their metabolic activity, as determined by the alamarBlue® dye agent, 
corresponds to the fluorescence ceiling to which the fluorescence of treated cells 
was compared. 
v. Media Blank. Each plate was designated at least one well of pure media to blank 
out fluorescent effects of media alone.  
vi. Cell Blank. In preliminary research, it was confirmed that both the media and the 
nanoparticles caused limited reduction of resazurin. For example, a well with 
media, dye, and AgCit at 10 µg/mL induced a fluorescent output of 639.7 relative 
fluorescence units (RFU). Therefore, it was decided that all treatments in the 
present study were to be accompanied by one well of their corresponding “cell 
blank,” wherein the same treatment was applied in the absence of cells. This 
fluorescent output was subtracted from the average fluorescence of treatments 
containing cells to cancel out the fluorescence noise unique to that treatment. 
 
4. Day 3: Fluorescence Inspection 
i. Fluorescence Theory. Fluorescence occurs when a molecule (here, resazurin) in 
its ground state absorbs an incident photon, causing the molecule to enter an 
electronically excited state.  The molecule will then undergo non-vibrational 
relaxation, collisional quenching, and/or heat release until it reaches the lowest 
vibrational level of its respective excited electronic state. Once this non-radiative 
decay is over, a photon is emitted to return the molecule back to one of the 
vibrational levels within its ground state. This emitted photon must be of a longer 
wavelength, or have less energy, than the incident photon because non-radiative 
decay occurred prior to its emission. This is the principle behind the Stokes Shift, 
or the wavelength difference between absorption and emission peaks.  
ii. alamarBlue® Dye Addition. 24 hours after AgNP treatments and controls were 
added, experimental plates were inspected again for contamination. This is to 
circumvent the possibility of microbial contamination creating false positives for 
metabolic activity. 11.5 µL of 10x alamarBlue® reagent was added to all test wells 
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on experimental plates besides those allocated for media fluorescence blanking. In 
addition, alamarBlue® reagent was added to a control plate to determine the 
quenching behavior of the treatments and the media. Plate lids were covered in 
sterilized aluminum foil to prevent light-induced reduction, and then returned to the 
incubator for another 8 hours to allow maximum resazurin reduction to take place. 
This optimum incubation period was chosen because it maximizes the amount of 
reduction that can take place, but isn’t so long that the positive control reduction 
reaction goes to completion such that relative fluorescence comparisons are skewed 
[31].  
iii. Plate Reader. After 8 hours, the plates were simultaneously removed from the 
incubator to ensure uniform incubation times with the alamarBlue® reducing agent 
(Figure 7). They were then allowed 30 minutes to return to room temperature before 
being inserted into a SpectraMax 360 fluorescent plate reader (Figure 8). This was 
done because increased temperature can influence fluorescence emissions by either 
raising the vibrational level of the fluorescent molecule, or by inducing 
conformational changes in the media proteins so that they cause quenching. The 
fluorescence excitation wavelength was chosen to be 555 nm, since the excitation 
range is 540–570 nm. The fluorescence cutoff was set to 570 nm, which truncates 
excitation radiation so it does not get picked up by the detector. Fluorescence peak 
emission was measured at 585 nm, since the total emission spectrum is 580–610 
nm. Fluorescence intensities were recorded in Excel.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. 96-well plate after eight hours of incubation with the viability dye. The more pink 
a well appears, the more resazurin reduction into resofurin has taken place, and thus the 
more metabolically active the well is. All the treated wells were initially blue, as this is the 
color of resazurin.  
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(1) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
iv. Reduction Calculations. Because resazurin reduction to resofurin is caused by 
cellular metabolic activity in the cell, and because metabolic activity is used to 
measure cell viability, results from this assay are quantified as % cell viability. This 
value represents the viability of treated cells relative to untreated cells. Specifically, 
relative chemical reduction of resazurin, and thus viability, was calculated by 
dividing the average fluorescence emission of the treatment wells by the average 
emission of the untreated, positive control wells. This is shown in Equation 1, 
 
                        % Cell Viability =  
 𝑭𝒂𝒗𝒈(𝟓𝟖𝟓𝒏𝒎) 𝒐𝒇𝒕𝒓𝒆𝒂𝒕𝒆𝒅 𝒄𝒆𝒍𝒍𝒔 (𝑹𝑭𝑼)
𝑭𝒂𝒗𝒈(𝟓𝟖𝟓𝒏𝒎) 𝒐𝒇 𝒖𝒏𝒕𝒓𝒆𝒂𝒕𝒆𝒅 𝒈𝒓𝒐𝒘𝒕𝒉 𝒄𝒐𝒏𝒕𝒓𝒐𝒍 (𝑹𝑭𝑼)
 x 100%     
 
where Favg(585nm) is the average 585 nm fluorescence emission of the treatment 
series eight and half hours after dye addition, and RFU is the fluorescence unit in 
which this average is measured. A cell viability value of 100% means the treatment 
had no effect on its target cell population, since these cells are just as metabolically 
active as the untreated control group. Conversely, a value of 0% means zero 
reduction of the dye agent occurred. This means the cells are either dead or non-
viable, which in either case means the treatments were effective at inhibiting the 
cell line.  
v. LD50 Calculation. The LD50 endpoint was calculated by linear interpolation 
between the two toxicity concentrations above and below the 50% cell viability 
point. LD50 calculations, even with the help of advanced software, are at best an 
estimate. However, LD50 values provide suitable quantifications of toxicity trends.  
 
 
 
Figure 8. SpectraMax 360 plate reader with plate drawer open. Excitation and emission 
wavelengths were set to 555 nm and 585 nm, respectively.   
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D. Dynamic Light Scattering (DLS) 
 
To verify AgNP diameters and test stability in biological media, AgCit and AgBPEI samples of 5 
µg/mL were subjected to temporal DLS testing (Figure 9). If the AgNPs aggregate when suspended 
in media, then size-dependent toxicity mechanisms can obfuscate the effects of surface charge. 
Therefore, AgNPs must maintain similar diameters in vitro for valid toxicity comparisons based 
on surface charge.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1. DLS Theory 
DLS provides the size and number distribution of particles in a solution by applying laser 
light scattering principles. For example, smaller particles exhibit enhanced Brownian 
motion over larger particles, so this increases Doppler shift effects in the light they scatter. 
A photon counter correlates these fluctuations in light scatter to their diffusion constant, 
which is used to calculate their hydrodynamic diameter (HDD) through the Stokes-Einstein 
equation.   
 
2. Sample Preparation 
Concentrations of 5 µg/mL were prepared for AgCit and AgBPEI in glass cuvettes 
containing either Milli-Q water or media. Because toxicity results indicated LD50s below 
5 µg/mL, and because aggregation effects usually increase with concentration, 5 µg/mL 
was chosen as the concentration above which aggregation behavior would be irrelevant 
because potential treatments would be confined to lower concentration ranges. The total 
volume of each cuvette was held to 0.8 mL. AgNP solutions in Milli-Q water were prepared 
to obtain baseline HDDs, whereas those in DMEM were prepared to test for aggregation. 
The DMEM solution contained the same FBS, penicillin streptomycin, amino acid, and 
Figure 9. The Wyatt Technologies DynaPro NanoStar in the Cal Poly Chemistry Department was 
used for DLS testing. 
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vitamin concentrations as the cell culturing media. In this way, the AgNP aliquots in media 
reflect the in vitro conditions experienced by the AgNPs during toxicity testing.  
 
3. pH Measurement 
Before testing, the DMEM solution was measured using a pH probe and found to have a 
pH of 7.27. This correlates well to the pH range of human blood, which is between 7.35 to 
7.45. In this way, there is an accurate model of physiological pH.  
 
4. Aggregation Kinetics 
Measurements were taken every five minutes for 45 minutes after the samples were 
prepared. This was done to allow sufficient time for nanoparticle aggregation to occur, as 
well as to detect any time-dependent stabilization behavior. Time t=0 min. represents a 
DLS reading immediately following the dispersal of AgNPs into the medium of interest (a 
process that took less than 1 minute). 
 
5. Parameters 
A reference sample consisting of polystyrene nanoparticles of known diameter was run to 
ensure DLS accuracy. When the DLS passed this control, the AgNPs were then tested. 10 
individual tests were run per time period, per AgNP. Each test consisted of 5 
measurements. Therefore, the HDDs presented are the average of 10 averages. 
 
 
III. Results and Discussion 
A. Viability Assay 
1. Trend of Superior AgBPEI Cytotoxicity  
Dose-dependent curves for HeLa and fibroblast cells are shown in Figures 10 and 11, 
respectively. Both figures illustrate a general trend in which AgBPEI is more cytotoxic 
than AgCit. This trend holds for both cell lines, as AgBPEI effectively induces total cell 
death at concentrations less than 5 µg/mL. This supports the initial hypothesis that AgBPEI 
would display enhanced cytotoxicity because AgBPEI’s positive surface charge facilitates 
increased Coulombic interactions with the negatively-charged cell surface.  On the 
contrary, AgCit’s negative surface charge discourages interaction with cells, thus 
attenuating cytotoxic response.  
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Figure 10. Dose-response curve for AgNP treatments on the cancerous cell line. AgBPEI displays 
superior toxicity to AgCit for all concentrations except 7.5 and 10 µg/mL where toxicity 
differences become statistically insignificant. The increase in cell viability as these latter 
concentrations is likely caused by AgNP aggregation. 
Figure 11. Dose-response curve for AgNP treatments on the fibroblast cell line. The 2.5 µg/mL 
treatment suggests that disparities in AgNP toxicity are evident mostly between 1 and 5 µg/mL. 
Outside of this concentration range, differences in AgNP toxicity are minimal.  
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It should be noted that while the differential AgNP toxicity trend ostensibly reverses in the 
HeLa line at 7.5 and 10 µg/mL concentrations, this difference is not statistically significant 
(t-test, p < 0.05) and can be attributed to AgNP aggregation and polydispersity.  
 
2. HeLa Trends 
i. Toxicity Decrease after 5 µg/mL. The general decrease in AgNP toxicity in the 
HeLa line above 5 µg/mL is likely due to concentration-enhanced aggregation 
effects. Aggregation diminishes AgNP cytotoxicity through several mechanisms 
[13]. First, because many AgNPs coalesce, there are less net particles in the treatment 
to cause toxic effects: there are less “bullets” to kill the cells. Second, because there 
are fewer small AgNPs and more large AgNPs, there is a net reduction in surface 
area available for Ag+ dissolution. Because ion dissolution is the predominant 
toxicity mechanism of AgNPs, this decreases AgNP toxicity. Third, larger, bulkier 
AgNPs have worse chances of permeating through the cell membrane or being 
endocytosed by the cell, thus decreasing the likelihood of AgNP interaction with 
the cell. Aggregation would also increase AgNP polydispersity, which exacerbates 
size-dependent toxicity effects and allows for increased deviation in toxicity 
between wells. This explains the large standard error bars on either treatment at 
these concentrations.  
 Another potential cause is that since both capping agents can be metabolized 
as food for the cells, metabolic increases to any surviving cells is possible. This 
would artificially increase fluorescence and subsequently cell viability. 
ii. HeLa Cell Sensitivity to Surface Charge Effects. The disparity in toxicity 
between AgNPs is especially prevalent in the HeLa cell line.  It is speculated that 
this is because surface charge effects are more pronounced in cancer cells, since 
cancer cells have a more negative surface charge than normal cells at physiological 
pH [22,25] . This is mostly because cancerous cells display enhanced glycolytic 
metabolism, meaning lactate anion secretion is increased significantly [32]. 
 
3. Fibroblast Trends 
i. No Toxicity Decrease after 5 µg/mL. Interestingly, the fibroblast cell line did not 
display the same reversal in toxicity with concentration that the HeLa line did. 
AgNP aggregation probably also occurred in the 3T3 treatments because of the 
similarity of in vitro environments between cell lines. Potential environmental 
discrepancies could be caused by the enhanced metabolic activity and population 
size of the cancer cell line, which would decrease pH [8] and increase lactate anion 
secretion. Nevertheless, because the media is buffered to prevent pH fluctuations 
and because the media has a high ionic strength, slight increases in H+ or anion 
presence would have minimal effect. However, the cytotoxicity-diminishing effect 
of AgNP aggregation would have been obfuscated in the 3T3 line because 
fibroblast cells divide less rapidly than do cancer cells, so the smaller fibroblast 
population was more sensitive to any toxic treatment of the same concentration.   
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ii. Differential Toxicity Window Between 1 and 5 µg/mL. Unlike HeLa cells, the 
3T3 cells displayed differential AgNP toxicity mostly in the concentration range 
between 1 and 5 µg/mL. The cause of this is presently unknown. Further testing of 
3T3 cells with AgNP treatments within this concentration range would help 
elucidate the nature of this trend.  
 
4. Comparing Cell Line Sensitivity  
i. Cancer Cells are Inherently More Viable. The HeLa cells were more robust to 
AgNP treatments for two reasons: the first is difference in population size. Given 
that approximately 1x104 cells were pipetted into each well, and that each well 
population had an equal amount of time for stabilization and growth, it can be 
assumed that the cell density per well is relatively constant per cell line.  However, 
this assumption does not hold when comparing different cell lines because of 
differences in growth rates. Both HeLa and 3T3 lines are immortalized cell lines, 
meaning that they have specific mutations that allow them to grow and divide 
indefinitely under suitable in vitro conditions. However, as verified by light 
microscope inspection during culturing, the HeLa cells used in this study displayed 
a faster rate of division than did the 3T3 cells. (This difference is caused by various 
genomic discrepancies, such as the HeLa cells’ dysregulated cell cycle and 
endogenous viral genes.) Consequently, after two days of incubation, the HeLa cell 
density per well was higher than the 3T3 cell density. This means there were fewer 
3T3 targets than HeLa targets for the same treatment concentration; in other words, 
the 3T3 line experienced a higher AgNP:cell ratio. Thus the 3T3 population was 
more susceptible to AgNP treatments purely on a numbers basis.    
 The second reason is that cancer cells have accelerated metabolic rates. This 
artificially increases viability measurements due to increased dye reduction and 
subsequently increased fluorescence. This means not only are there more cancer 
cells than fibroblasts per well, but each cancer cell is more metabolically active 
than a fibroblast cell. Therefore, even if cell populations were identical at the time 
of alamarBlue® addition, the HeLa cells would consistently reduce more resazurin 
and appear more viable.  
 Taking these two considerations together, cancer cells are inherently harder 
to kill than healthy cells because they have more effective metabolisms and higher 
division rates. These effects must be taken into account when comparing the two 
cell lines, especially within the context of a dye-based viability assay. Even if 
individual cancer cells are mechanistically more susceptible to AgNP treatments, 
as suggested by past toxicity research [8,18], it would not appear that way because of 
the nature of this test.  
ii. Low Concentration Trends. The toxicity explanation concerning AgNP:cell 
ratios and metabolic differences suggests toxicity towards 3T3 cells should be 
enhanced across all treatment concentrations. However, this is not always the case. 
 AgCit toxicity from 0.5-2.5 µg/mL is comparable in both cell lines. Since 
low concentration treatments imparted fewer overall particles to elicit cytotoxic 
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response, the AgNP:cell ratio was low in both cell lines—regardless of differences 
in population. At such low concentrations, there might be insufficient therapeutic 
agents to cause detectable metabolic effects in the whole cell population. In this 
way, AgNP concentration may be more of a toxicity factor than population size 
because it scales multiplicatively. 
 Similarly contrary to expectations, AgBPEI is more toxic towards the HeLa 
cells than towards 3T3 cells at these lower concentrations. Again, this is likely a 
byproduct of the HeLa cells’ more negative surface charge, a factor that could 
supersede the toxicity-buffering effects of increased population size and 
metabolism.  
 
B. LD50 Values 
1. Superior AgBPEI Toxicity 
LD50 values for the silver treatments were calculated by linear interpolation to quantify the 
trends depicted in the dose-response curves (Table II). Results reveal the superior toxicity 
of AgBPEI over both AgCit and Ag+ to either cell line.  Compared to AgCit, AgBPEI was 
approximately 84% more cytotoxic to HeLa cells and about 65% more cytotoxic to 
fibroblast cells. (These values are estimates due to the approximate nature of LD50 
calculations, the non-linearity of the dose-response curves, and the limited number of data 
points.) However, while the veridical LD50 may be, for example, +/- 10% of the calculated 
values, the trend of superior AgBPEI cytotoxicity would not disappear. In this way, these 
values serve as a useful tool to compare cytotoxicity, though they should not obviate the 
need for high-throughput calculations before integration into clinical applications. 
 
 
 
Cell Treatment LD50 (µg/mL) 
HeLa 
AgBPEI 3.2 
AgCit 5.9 
Ag+ 3.5 
3T3 
AgBPEI 2.3 
AgCit 3.8 
Ag+ 3.3 
 
2. Ag+ Toxicity 
It is interesting to note that the Ag+ control treatment was less toxic than the AgBPEI to 
either cell line. This contradicts the widely-held belief that the toxicity of AgNPs is due to 
ion dissolution alone, and instead supports more recent work showing that physical 
interactions between AgNPs the target cell also contribute to toxicity.  This controversy 
originated from a landmark 2012 paper by Alvarez et al. claiming that negligible 
nanoparticle-specific toxicity mechanisms exist [33].  
Table II. Calculated LD50 Values of Silver Treatments  
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 Any Ag+ treatment will have more free ions in solution than will a AgBPEI 
treatment at any given concentration, so if ionic silver release were the sole toxicity 
mechanism of AgNPs, then Ag+ should be more cytotoxic than AgBPEI, not less. 
Therefore, there must be some physical toxicity factor unique to AgNPs. This agrees with 
recent research indicating that toxicity mechanisms differ between ionic silver and AgNPs 
[10]. Moreover, the fact that AgBPEI is more toxic than Ag+, whereas AgCit is less toxic, 
provides further evidence that surface charge-influenced physical interactions between the 
AgNP and the cell membrane may be the foundation of nanoparticle-specific toxicity 
mechanisms.  
 
3. Capping Agent Toxicity 
Capping agent treatments, at effective concentrations (10 µg/mL) much higher than would 
be seen by a AgNP treatment of the same concentration, had either negligible cytotoxic 
effects or increased the metabolic activity of the treated cells (Table III). The % cell 
viability after treatment with capping agents is near or over 100%. This means that even at 
the highest concentration of AgNPs, the presence of capping agent has no confounding 
effect on the cytotoxicity measurements. Citrate is a known substrate for energy generation 
in mammalian glycolytic and Krebs cycle pathways [34], so it makes sense that it seemed to 
increase the viability of treated cells. Similarly, results suggest polyethylenimine also 
stimulates metabolic activity, potentially as a base molecule for catabolic breakdown. 
 
 
 
 
 
 
 
 
 
This means AgNP toxicity results from nanoparticle and Ag+ mechanisms, and that capping 
agents alone have no considerable obfuscating effect on toxicity measurements. If 
anything, because free BPEI in the growth media seems to increase cell viability moreso 
than citrate, AgBPEI could be slightly more toxic than the viability assay suggests. 
However, such a conclusion is unnecessary because the trend of superior toxicity of 
AgBPEI is already well established and because the concentration of free floating BPEI at 
AgBPEI treatments of 5µg/mL is far less than BPEI treatments at 10 µg/mL.  
 
C. AgNP Aggregation 
1. DLS Results 
To isolate surface charge as the only independent variable capable of influencing 
cytotoxicity comparisons, AgBPEI and AgCit were ordered at the same diameter. 
However, because the AgNPs were then placed in media—a solution different than that in 
which the AgNPs were synthesized and characterized—it was necessary to remeasure 
Cell Capping Agent Cell Viability 
HeLa  
BPEI 108.2 % 
Citrate 97.2 % 
3T3  
BPEI 119.2 % 
Citrate 111.6 % 
Table III. Capping Agent Cytotoxicity 
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AgNP size in media. To deconvolute the effects of potential aggregation on cytotoxicity 
and model AgNP stability, HDD was measured for both types of AgNP in test media at 5 
µg/mL using DLS (Table IV).  While it would appear thus far that surface charge was the 
only toxicity parameter that varied between AgBPEI and AgCit, DLS results suggest 
otherwise.  
 
 
 
AgNP Time (min) Watera (nm) % Intensityb Media (nm) % Intensity 
AgBPEI 
0 44.2 96.8 119.6 94.3 
10 46.3 98.3 141.8 94.2 
25 46.0 94.8 140.5 95.5 
AgCit 
0 46.1 97.1 polydisperse N/A 
10 49.7 98.2 polydisperse N/A 
25 49.3 96.5 polydisperse N/A 
 
Once diluted to 5 µg/mL in Milli-Q water, both types of AgNPs showed slight 
aggregation to the effect of a several nanometer HDD increase. However, HDDs 
stabilized after 25 minutes. Since size is indirectly calculated from an experimentally 
derived diffusion coefficient rather than direct measurement, and because HDD includes 
the radius of the protruding capping agents, an increase of three nanometers can be 
considered negligible. This supports the 40 nm diameter TEM measurements provided by 
nanoComposix, which only measure the silver core.  
 However, both AgNPs aggregated in media. Whereas the AgBPEI HDD 
stabilized at roughly 140 nm after 10 minutes, AgCit rapidly agglomerated into a wide 
range of large HDDs that increased with time (Appendix B). (Here agglomerated is 
defined as rapid aggregation behavior that will continue indefinitely until the nanoparticle 
falls out of suspension.) This means that AgCit is not stable in the test media, and that the 
AgNP treatment HDDs in the viability assay were not constant. Thus, cytotoxicity 
differences between the types of AgNPs cannot be attributed solely to surface charge, and 
size-dependent toxicity effects must be taken into account when interpreting the toxicity 
results.  
 
2. AgBPEI more Bioavailable than AgCit 
As previously mentioned, an increase in AgNP diameter corresponds to reduced particle 
count, reduced surface area for ion dissolution, and hindered ability to enter the cell: all of 
which result in decreased cytotoxic effects [13]. It should be noted that because of the 
limitations of HDD measurements, it is not known whether individual AgNPs aggregated 
into a multi-particle cluster or physically coalesced into a single, large particle. The 
Table IV. Hydrodynamic Diameters of AgNPs  
a Water controls (blue) were used to verify AgNP stock HDD and to act as a reference to which 
aggregation in media can be compared.  
b % Intensity, or the relative amount of scattering intensity, was used to determine the true HDD 
average within the size distribution chart. See Appendix B for sample size distributions and 
autocorrelation curves for details on how % Intensity was used.  
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cytotoxic differences between the two are also unknown, although in either case toxicity 
would still decrease. Therefore, if AgNP aggregation occurs, its mechanisms of interaction 
with the target cells are attenuated. This is especially the case if the AgNP becomes so 
large that it falls out of suspension and is not available to physically interact with the target 
cells. So not only was there a repulsive Coulombic force between the AgCit and the target 
cells’ membrane, but AgCit’s agglomeration in vitro further reduced its likelihood of 
interacting with the cells. In this way, AgBPEI is more “bioavailable” than AgCit because 
AgBPEI is more available in the biological environment to interact with cells. Although 
surface charge effects are not solely responsible, this increased bioavailability directly 
correlates to increased cytotoxicity. Therefore, AgBPEI’s enhanced bioavailability makes 
it a superior nanoparticle over AgCit for targeted tumor therapies and other such inherent 
toxicity applications.  
  
3. Aggregation Mechanisms 
The stability of colloidal nanosilver is contingent on surface interactions with its solution. 
Specifically, the physico-chemical properties of the AgNP capping agents determines how 
salts, proteins, and other biomolecules in media will interact with the AgNPs. Similarly, 
solution properties such as pH, solvent polarity, and solute composition and concentration 
influence AgNP aggregation [35]. 
i. Capping Agents. Both capping agents are physisorbed onto the silver core through 
secondary bond interactions.  
 BPEI, a heavily branched dendrimer, stabilizes AgBPEI by providing a tree-
like network of polymer chains that mechanically obstructs AgBPEI from 
coalescing. This steric hindrance can utilize osmotic pressure gradients and coil 
compression mechanisms to discourage AgBPEI aggregation [36]. Additionally, 
BPEI also offers electrostatic repulsion by virtue of the net positive charge imparted 
by its amine groups, which are protonated in solution. This means the AgBPEI 
Coulombically repels other positively-charged AgBPEI.  
 On the other hand, citrate capping agents are limited to electrostatic 
repulsion. Citrate is a derivate of citric acid, and is a polyatomic anion (C6H5O7
3− ) 
in solution. Its negative charge repels other negatively charged AgCit. Because the 
silver nanoparticle core also has a slight negative charge, citrate binds more weakly 
to the silver nanoparticle than BPEI [27]. 
 Since BPEI provides electrosteric repulsion, as opposed to simply 
electrostatic repulsion, it is generally considered a more stable capping agent than 
citrate [35].   
ii. AgBPEI. In the case of AgBPEI aggregation, two explanations are possible: either 
counterions and proteins from the media formed complexes with the nanoparticles, 
or they initiated PEI bridging behavior that joined the nanoparticles through an 
anion intermediate [35]. This would reflect an effective increase of AgBPEI size, 
rather than AgBPEI aggregation. While the ionic strength of the media may have 
diminished electrostatic stability mechanisms, steric hindrance would have 
remained unaffected. Since AgBPEI retained at least one mechanism of 
maintaining colloidal stability, agglomeration did not occur.  
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iii. AgCit. Conversely, cations present in the media could have been sufficient to 
initiate AgCit agglomeration. In accordance to DLVO theory [37], compression of 
AgCit’s diffuse double layer would weaken electrostatic repulsion and increase the 
likelihood of macroscopic van der Waals interactions (Hamaker attraction). The 
weak polar association of citrate with the silver core exacerbates this trend by 
providing negligible steric hindrance. Additionally, because citrate is easily 
displaced, this allows for temporary exposures of the silver core to the surrounding 
media. If enough surface area is exposed, then surface energy can provide sufficient 
driving force to encourage nanoparticle coalescence. 
 It should be noted that in some cases AgCit does not show the aggregation 
effects found in this study. This is due to the variability of in vitro conditions, such 
as cell byproducts or test media’s pH, dilution strength, or composition.  
 
4. Surface Charge vs. Size Effects on Toxicity 
Because of the competing effects of surface charge and size on cytotoxicity, the viability 
data cannot be used to support the hypothesis regarding the surface charge dependent 
cytotoxicity of AgNPs. Without definitive knowledge concerning their relative impacts, 
these two toxicity variables cannot be decoupled. That being said, although the initial 
hypothesis cannot be explicitly supported, DLS results don’t negate its validity. Prior 
research still supports surface charge dependent cytotoxicity, and AgBPEI’s significantly 
enhanced toxicity is most likely at least partially due to its surface charge.  
 
 
IV. Conclusions 
 
AgBPEI is more toxic to human cells than AgCit. AgBPEI’s superior cytotoxicity can be explained 
by enhanced bioavailability to the target cells. Compared to AgCit, AgBPEI has a Coulombic 
propensity, rather than an aversion, to interact with mammalian cell membranes. Moreover, AgCit 
agglomerated to large sizes in test media, hindering the likelihood of cell association and 
diminishing cytotoxic effects. While this prevents conclusions regarding surface charge-dependent 
toxicity from being made, it reveals that AgBPEI is a more stable nanoparticle than AgCit under 
in vitro conditions. 
 
Additionally, AgBPEI was more toxic than Ag+ to both HeLa cells and 3T3 cells. Therefore, 
AgBPEI toxicity mechanisms cannot be confined to Ag+ dissolution alone, because otherwise this 
toxicity trend would be reversed. Although an auxiliary objective of this research, this is of interest 
to the nanosilver academic community and should be considered when evaluating AgNP toxicity 
mechanisms. 
 
Lastly, because cancer cells have more negatively charged membranes than healthy cells, the 
difference in toxicity between AgBPEI and AgCit was more apparent in the HeLa line than the 
fibroblast line. Apparent discrepancies in susceptibility to AgNP treatments between the two cell 
lines should be attributed to differences in population size and metabolic activity, and does not 
necessarily reflect preferential toxicity.  
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V. Recommendations 
 
Cancer researchers investigating AgNPs for targeted tumor applications should use AgBPEI over 
AgCit on the premise of increased physiological stability and toxicity. Citrate is a commonly used 
capping agent for AgNP inherent toxicity studies because of its pre-existing wealth of data and the 
relative ease of AgCit synthesis. However, BPEI is a more stable capping agent that has been 
shown to increase the biocidal effects of nanosilver in both microbes and eukaryotes. 
 
VI. Future Work 
 
The next step in this research is to retest AgBPEI against a negatively-charged AgNP that is stable 
in test media. This would isolate surface charge as the only independent variable and eliminate 
aggregation effects as a source of error. For the sake of economy, AgCit will be retested in a 
different, more dilute culture media before other AgNPs are explored. Once a stable, negatively-
charged AgNP has been identified, the alamarBlue® viability assay will be run with high 
throughput techniques to improve LD50 accuracy. Once this is complete, a complementary toxicity 
assay should be pursued to corroborate the viability assay results. To this end, the Annexin V 
propidium iodide stain has been chosen and its necessary lab equipment (such as a flow cytometer) 
has been secured. This assay will also help differentiate apoptotic from necrotic effects, and can 
provide additional information regarding the cytotoxicity mechanisms of AgNPs. 
 
If the hypothesis regarding surface charge-dependent cytotoxicity holds, AgNP researchers should 
begin comparing the cytotoxicity of various positively-charged AgNP to determine an optimal 
AgNP for inherent toxicity applications. With the optimal capping agent found, the tumor targeting 
phase of this research can begin. It may then also be beneficial for targeting moieties to maintain 
a net positive surface charge to enhance their likelihood of cellular interaction. However, it should 
not endanger cancer cell specificity, so as not to deliver AgNPs to healthy tissue. At the very least, 
targeting moieties should avoid highly negative surface charges at physiological pH to enhance 
the likelihood of interaction with cells of interest. 
Lastly, investigations into the physical interaction with the nanoparticle and the cell membrane 
will not only help facilitate targeting research, but can also provide insight into toxicity 
mechanisms that differentiate AgNPs from Ag+. 
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IX. Appendix 
 
A. Safety and Handling Protocols 
1. Disposal & Handling of Nanoparticles 
Because of their large surface-to-volume ratio, nanoparticles are very reactive. AgNPs in 
particular can cause adverse environmental impacts, and exhibit a cytotoxic effect to both 
microbial and animal cells [2]. Therefore, it is imperative that AgNPs are handled and 
disposed of properly. Environmental, safety, and health standards of nanoparticle 
handling were followed according to protocols developed by the Department of Energy 
Nanoscale Science Research Centers [38]. 
 The nanoparticles utilized in this study are contained within an aqueous solution, 
so respiratory issues are not of concern [39]. Still, protective equipment such as gloves, lab 
coats, and closed toed shoes were worn to prevent AgNP interactions with exposed 
skin. Surfaces in the vicinity of AgNP handling (lab tabletops, benches, chairs, fume 
hood, and other various lab equipment) were wiped with a damp rag to encourage 
entrapment and coagulation of any lingering nanoparticles. This rag was soaked in water 
and then rinsed and washed with conventional methods. This contaminated water was 
then treated with dilute amounts of HNO3 and poured into the AgNP waste container. In 
the event of a spill over 50 mL, a chloride containing solution would have been poured 
over the spill and wiped up with the rag. Chloride ions encourage AgNP agglomeration to 
microscopic sizes, which diminishes cytotoxic effects and makes cleanup easier.  
 When the experiment was finished, all glassware in contact with silver 
nanoparticles was rinsed with deionized water, which was then poured into a designated 
AgNP waste container. Once sufficient rinses were conducted, HNO3 was added to the 
glassware to dissolve any remaining bulk silver and poured into the AgNP waste 
container. The glassware was then washed and dried per usual laboratory procedure.  The 
designated waste container was flagged with an EHS (Cal Poly Environmental Health 
and Safety) chemical waste disposal form, placed under a fume hood, and scheduled for 
disposal. 
 
2. AgNP Storage  
AgNPs are most stable (least likely to aggregate) at reduced temperatures and minimal 
lighting. AgNPs were cold shipped and upon arrival stored, sealed, and wrapped in 
aluminum foil in a laboratory refrigerator (4o C). All nanoparticle handling was 
conducted in sterile atmospheres to eliminate the chances of endotoxin contamination, 
which might have interfered with the toxicity profile of the nanoparticle.  
 
3. Biological Handling  
Because all biological agents are eukaryotic mammalian cells, there was no immediate 
biosafety hazard [26]. However, the possibility of microbial contamination necessitated 
adherence to anti-microbial protocols.  
 Cell lines were only exposed to sterile environments to prevent contamination. To 
accomplish this, cell line flasks were opened only in a vacuum hood after the hood 
surface and all its contents were subject to 20 minutes of UV radiation and a 70% ethanol 
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spray. (A stronger solution would encourage protein coagulation before the alcohol could 
reach and kill all the cytoplasmic constituents of the contaminating microbe, and would 
thus be less effective). Disposable nitrile gloves were worn during all times and replaced 
every time a new biological item was handled to mitigate chances of cross-
contamination.  
 Cal Poly’s Institutional Review Board guidelines for the protection of human 
subjects were not applicable to this research since the provided cells were not from living 
sources. 
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B. Sample DLS Data: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
Dataset 1. The size distribution (top) of AgBPEI in 
media after 25 minutes reveals how % intensity (y-axis) 
peak was used to determine the average HDD reported 
in Table IV. This sample’s respective auto-correlation 
curve (bottom) was included to illustrate data validity.   
 
 
Dataset 3. AgCit agglomeration immediately following dilution in media (top left) and after 25 minutes (top right). 
These size distributions are polydisperse, as indicated by multiple % intensity peaks. It is evident that the size 
distribution continues to widen with time. Respective autocorrelation graphs (bottom left, bottom right) contain two 
curves each, revealing the polydispersity of the samples. 
Dataset 2: The 25 minute, AgCit in water sample 
showed the same small signal at 2-3 nm as in Dataset 
1. This illustrates an experimental artifact of DLS 
testing.  
